LT3554491T - N-acetilcisteinas, skirtas naudoti kaip antibakterinis agentas - Google Patents

N-acetilcisteinas, skirtas naudoti kaip antibakterinis agentas

Info

Publication number
LT3554491T
LT3554491T LTEPPCT/EP2017/082512T LT17082512T LT3554491T LT 3554491 T LT3554491 T LT 3554491T LT 17082512 T LT17082512 T LT 17082512T LT 3554491 T LT3554491 T LT 3554491T
Authority
LT
Lithuania
Prior art keywords
acetylcysteine
antibacterial agent
antibacterial
agent
Prior art date
Application number
LTEPPCT/EP2017/082512T
Other languages
English (en)
Inventor
Gian Maria Rossolini
Lucia PALLECCHI
Francesco SERGIO
Original Assignee
Zambon S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon S.P.A. filed Critical Zambon S.P.A.
Publication of LT3554491T publication Critical patent/LT3554491T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LTEPPCT/EP2017/082512T 2016-12-15 2017-12-13 N-acetilcisteinas, skirtas naudoti kaip antibakterinis agentas LT3554491T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16204412 2016-12-15
PCT/EP2017/082512 WO2018108960A1 (en) 2016-12-15 2017-12-13 N-acetylcysteine for use as antibacterial agent

Publications (1)

Publication Number Publication Date
LT3554491T true LT3554491T (lt) 2023-05-25

Family

ID=57614136

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/EP2017/082512T LT3554491T (lt) 2016-12-15 2017-12-13 N-acetilcisteinas, skirtas naudoti kaip antibakterinis agentas

Country Status (20)

Country Link
US (2) US20200093774A1 (lt)
EP (2) EP3861994A1 (lt)
JP (1) JP2020502096A (lt)
CN (1) CN110049761A (lt)
AU (1) AU2017376391B2 (lt)
BR (1) BR112019011708A2 (lt)
CA (1) CA3045730A1 (lt)
CO (1) CO2019006311A2 (lt)
DK (1) DK3554491T3 (lt)
EA (1) EA201991331A1 (lt)
ES (1) ES2942764T3 (lt)
FI (1) FI3554491T3 (lt)
HR (1) HRP20230369T1 (lt)
HU (1) HUE061995T2 (lt)
LT (1) LT3554491T (lt)
PL (1) PL3554491T3 (lt)
PT (1) PT3554491T (lt)
RS (1) RS64201B1 (lt)
SI (1) SI3554491T1 (lt)
WO (1) WO2018108960A1 (lt)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1231012B (it) * 1989-07-27 1991-11-08 Zambon Spa Composizione farmaceutica per uso orale contenente nac.
AU2042200A (en) * 1998-12-07 2000-06-26 Baylor College Of Medicine Preventing and removing biofilm from the surface of medical devices
US7214364B2 (en) * 2000-12-27 2007-05-08 Corus Pharma, Inc. Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
US6566401B2 (en) 2001-03-30 2003-05-20 The Board Of Trustees Of The Leland Stanford Junior University N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
ITMI20021405A1 (it) * 2002-06-25 2003-12-29 Zambon Spa Composizioni farmaceutiche per il trattamento di infezioni da patogeni dell'apparato respiratorio
US8148356B2 (en) * 2005-08-24 2012-04-03 Cumberland Pharmaceuticals, Inc. Acetylcysteine composition and uses therefor
CA2662636C (en) 2008-04-15 2017-01-24 The Board Of Trustees Of The Leland Stanford Junior University N-acetylcysteine compositions and methods for treating acute exacerbations of inflammatory lung disease
GB0905451D0 (en) * 2009-03-31 2009-05-13 Novabiotics Ltd Biofilms
IT1399492B1 (it) 2010-04-13 2013-04-19 Alpex Pharma Sa Composizioni farmaceutiche effervescenti contenenti n-acetilcisteina.
GB201021186D0 (en) * 2010-12-14 2011-01-26 Novabiotics Ltd Composition
ITMI20130874A1 (it) 2013-05-29 2014-11-30 Zambon Spa Compresse deglutibili di n-acetilcisteina
BR112016003481A2 (pt) * 2013-08-23 2020-03-03 Parion Sciences, Inc. Agentes mucolíticos de ditiol
WO2016120787A1 (en) 2015-01-26 2016-08-04 Novartis Consumer Health S.A. Oral n-acetylcysteine in the treatment of upper respiratory tract infections and symptoms

Also Published As

Publication number Publication date
JP2020502096A (ja) 2020-01-23
ES2942764T3 (es) 2023-06-06
EP3554491B1 (en) 2023-02-15
HUE061995T2 (hu) 2023-09-28
US20210113508A1 (en) 2021-04-22
US11918552B2 (en) 2024-03-05
CO2019006311A2 (es) 2020-01-17
DK3554491T3 (en) 2023-05-15
EA201991331A1 (ru) 2019-11-29
EP3554491A1 (en) 2019-10-23
RS64201B1 (sr) 2023-06-30
BR112019011708A2 (pt) 2019-10-15
FI3554491T3 (fi) 2023-04-26
CA3045730A1 (en) 2018-06-21
WO2018108960A1 (en) 2018-06-21
HRP20230369T1 (hr) 2023-06-23
PT3554491T (pt) 2023-05-04
AU2017376391B2 (en) 2023-06-01
AU2017376391A1 (en) 2019-06-20
US20200093774A1 (en) 2020-03-26
EP3861994A1 (en) 2021-08-11
SI3554491T1 (sl) 2023-06-30
CN110049761A (zh) 2019-07-23
PL3554491T3 (pl) 2023-07-17

Similar Documents

Publication Publication Date Title
HK1254677A1 (zh) 抗細菌化合物
HK1258690A1 (zh) 食品改良劑
EP3102193A4 (en) Antibacterial agents: n(alpha)-aroyl-n-aryl-phenylalaninamides
PL3481933T3 (pl) Środek zapobiegający szarzeniu
GB201521709D0 (en) PBD Antibacterial agents
EP3105244A4 (en) Antibacterial agents
GB201516614D0 (en) Antibacterial compounds
HK1253779A1 (zh) 止癢劑
GB201714777D0 (en) Agent
GB201620641D0 (en) Agent
EP3209667A4 (en) Nargenicin compounds and uses thereof as antibacterial agents
ZA201706866B (en) Water-based disinfectant
PL3413712T3 (pl) Środek dezynfekujący
LT3554491T (lt) N-acetilcisteinas, skirtas naudoti kaip antibakterinis agentas
GB201602235D0 (en) Antibacterial compounds
IL263877A (en) Magnesium ions as an antibacterial agent
GB201704297D0 (en) Antibacterial agents
EP3413713C0 (de) Desinfektionsmittel
GB201508497D0 (en) Antibacterial agent
AU2016903137A0 (en) Antibacterial Agent
HUE052800T2 (hu) Kontrasztanyagok
ZA201700064B (en) Pharmaceutical compositions comprising antibacterial agents
AU2015903173A0 (en) Antibacterial Agent
GB201615829D0 (en) Antibacterial compounds
GB201616460D0 (en) Antibacterial compounds